Doximity (DOCS) Competitors $57.53 -0.30 (-0.52%) (As of 01:09 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends DOCS vs. NET, HUBS, RBLX, VEEV, ZS, BIDU, IOT, ZM, PTC, and CHKPShould you be buying Doximity stock or one of its competitors? The main competitors of Doximity include Cloudflare (NET), HubSpot (HUBS), Roblox (RBLX), Veeva Systems (VEEV), Zscaler (ZS), Baidu (BIDU), Samsara (IOT), Zoom Video Communications (ZM), PTC (PTC), and Check Point Software Technologies (CHKP). These companies are all part of the "computer software" industry. Doximity vs. Cloudflare HubSpot Roblox Veeva Systems Zscaler Baidu Samsara Zoom Video Communications PTC Check Point Software Technologies Doximity (NASDAQ:DOCS) and Cloudflare (NYSE:NET) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk. Do institutionals and insiders hold more shares of DOCS or NET? 87.2% of Doximity shares are owned by institutional investors. Comparatively, 82.7% of Cloudflare shares are owned by institutional investors. 37.4% of Doximity shares are owned by company insiders. Comparatively, 12.8% of Cloudflare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer DOCS or NET? In the previous week, Cloudflare had 12 more articles in the media than Doximity. MarketBeat recorded 26 mentions for Cloudflare and 14 mentions for Doximity. Doximity's average media sentiment score of 0.71 beat Cloudflare's score of 0.61 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 4 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cloudflare 10 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is DOCS or NET more profitable? Doximity has a net margin of 33.69% compared to Cloudflare's net margin of -5.97%. Doximity's return on equity of 19.79% beat Cloudflare's return on equity.Company Net Margins Return on Equity Return on Assets Doximity33.69% 19.79% 16.86% Cloudflare -5.97%-7.18%-2.12% Which has preferable earnings and valuation, DOCS or NET? Doximity has higher earnings, but lower revenue than Cloudflare. Cloudflare is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDoximity$516.85M20.89$147.58M$0.8766.47Cloudflare$1.57B24.60-$183.95M-$0.26-433.42 Does the MarketBeat Community favor DOCS or NET? Cloudflare received 122 more outperform votes than Doximity when rated by MarketBeat users. Likewise, 49.18% of users gave Cloudflare an outperform vote while only 39.19% of users gave Doximity an outperform vote. CompanyUnderperformOutperformDoximityOutperform Votes5839.19% Underperform Votes9060.81% CloudflareOutperform Votes18049.18% Underperform Votes18650.82% Which has more risk & volatility, DOCS or NET? Doximity has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Cloudflare has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Do analysts prefer DOCS or NET? Doximity presently has a consensus price target of $52.59, suggesting a potential downside of 9.06%. Cloudflare has a consensus price target of $97.81, suggesting a potential downside of 13.20%. Given Doximity's stronger consensus rating and higher possible upside, equities analysts clearly believe Doximity is more favorable than Cloudflare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Doximity 0 Sell rating(s) 13 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.40Cloudflare 4 Sell rating(s) 12 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.29 SummaryDoximity beats Cloudflare on 13 of the 19 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Doximity News Delivered to You Automatically Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOCS vs. The Competition Export to ExcelMetricDoximityCustom computer programming services IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.80B$7.35B$5.15B$9.08BDividend YieldN/A2.45%5.12%4.25%P/E Ratio66.4716.9787.1117.18Price / Sales20.899.391,116.56117.12Price / Cash56.9721.7643.2337.85Price / Book11.976.124.794.78Net Income$147.58M$198.17M$120.55M$225.60M7 Day Performance8.54%1.69%-1.49%-1.36%1 Month Performance19.98%33.90%13.65%0.20%1 Year Performance107.13%35.36%28.61%15.30% Doximity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOCSDoximity3.0122 of 5 stars$57.53-0.5%$52.59-8.6%+107.1%$10.74B$516.85M66.13890Analyst ForecastPositive NewsNETCloudflare3.9702 of 5 stars$114.36+0.7%$95.20-16.8%+33.6%$39.25B$1.57B-436.923,682Insider TradeHUBSHubSpot4.2462 of 5 stars$741.88+2.8%$702.23-5.3%+24.0%$38.30B$2.17B-2,711.017,663RBLXRoblox1.9004 of 5 stars$61.26+2.8%$55.67-9.1%+30.8%$37.22B$2.80B-36.342,457VEEVVeeva Systems4.7774 of 5 stars$226.02-1.2%$255.73+13.1%+17.4%$36.69B$2.66B56.207,172Analyst ForecastPositive NewsZSZscaler4.2648 of 5 stars$203.81+2.7%$224.84+10.3%-15.5%$31.27B$2.17B-808.927,348Analyst RevisionBIDUBaidu4.5092 of 5 stars$88.89-2.1%$113.75+28.0%-25.2%$31.17B$134.84B11.1239,800IOTSamsara2.7047 of 5 stars$46.30+0.5%$51.29+10.8%+30.3%$25.76B$1.18B-98.042,895ZMZoom Video Communications3.9453 of 5 stars$83.55-0.3%$85.19+2.0%+18.1%$25.61B$4.53B27.937,420PTCPTC4.8412 of 5 stars$201.64+1.5%$205.67+2.0%+7.8%$24.22B$2.30B63.887,501CHKPCheck Point Software Technologies4.2709 of 5 stars$190.70+1.6%$197.74+3.7%+23.5%$20.97B$2.52B25.656,450Analyst Revision Related Companies and Tools Related Companies NET Alternatives HUBS Alternatives RBLX Alternatives VEEV Alternatives ZS Alternatives BIDU Alternatives IOT Alternatives ZM Alternatives PTC Alternatives CHKP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DOCS) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
